Skip to search formSkip to main contentSkip to account menu

redaporfin

Known as: 5,10,15,20-tetrakis(2,6-difluoro-3-N-methylsulfamoylphenyl)bacteriochlorin, LUZ11 compound 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

PorphyrinsSulfonamides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Investigation of the implications of atropisomersim for redaporfin-photodynamic therapy efficacy (Conference Presentation)
2019
2019
Combinatorial approaches with vascular photodynamic therapy with redaporfin and immune checkpoint blockers (Conference Presentation)
2017
2017
A first in human study using photodynamic therapy with Redaporfin in advanced head and neck cancer.
e14056Background: Photodynamic therapy (PDT) may be an appealing approach when head and neck cancer (HNC) patients (pts) develop… 
2017
2017
Photodynamic therapy with redaporfin induces ER stress and immunogenic cell death
2015
2015
Impact of photodynamic therapy with the photosensitizer redaporfin in distant metastasis
Metastatic diseases are the main cause of death of cancer patients. Thus, treating cancer disease requires therapies capable of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)